Incruse Ellipta

Product NDC
0173-0873
11-digit product format
001730873
Labeler code
0173
Product ID
0173-0873_4049ca45-7739-4d4a-bcce-50c5b3c7415f
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
umeclidinium
Dosage form
AEROSOL, POWDER
Route
ORAL
Labeler
GlaxoSmithKline LLC
Application
NDA205382
Marketing category
NDA
Marketing start
2014-04-30
Substance
UMECLIDINIUM BROMIDE
Active strength
62.5 ug/1
Pharmacologic classes
Anticholinergic [EPC], Cholinergic Antagonists [MoA]
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N205382-001INCRUSE ELLIPTAUMECLIDINIUM BROMIDEEQ 0.0625MG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-30

Orange Book patents#

Current patent rows page 1 of 1 · 1 matching rows.

Application-product, Patent, Expiration table
Application-productPatentExpirationUse codeCoverage / statusSubmission date
N205382-00174888272027-12-18Drug substance, Drug product2014-05-21

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N205382-001INCRUSE ELLIPTAEQ 0.0625MG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-3084e616aacf4f…
2026-08-18 06:07:402026-07N205382-001INCRUSE ELLIPTAEQ 0.0625MG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-30caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N205382-001INCRUSE ELLIPTAEQ 0.0625MG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-30011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N205382-001INCRUSE ELLIPTAEQ 0.0625MG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-3031067a03dcf5…
2025-08-23 18:47 UTC2025-08N205382-001INCRUSE ELLIPTAEQ 0.0625MG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-306a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N205382-001INCRUSE ELLIPTAEQ 0.0625MG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-30fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N205382-001INCRUSE ELLIPTAEQ 0.0625MG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-30b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N205382-001INCRUSE ELLIPTAEQ 0.0625MG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-3003ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N205382-001INCRUSE ELLIPTAEQ 0.0625MG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-302680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N205382-001INCRUSE ELLIPTAEQ 0.0625MG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-305bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N205382-001INCRUSE ELLIPTAEQ 0.0625MG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-30d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N205382-001INCRUSE ELLIPTAEQ 0.0625MG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-30d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N205382-001INCRUSE ELLIPTAEQ 0.0625MG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-3079d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N205382-001INCRUSE ELLIPTAEQ 0.0625MG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-30301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N205382-001INCRUSE ELLIPTAEQ 0.0625MG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-301e350fbaab3a…
2024-05-31 18:47 UTC2024-05N205382-001INCRUSE ELLIPTAEQ 0.0625MG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-308072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N205382-001INCRUSE ELLIPTAEQ 62.5MCG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-305c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N205382-001INCRUSE ELLIPTAEQ 62.5MCG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-305d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N205382-001INCRUSE ELLIPTAEQ 62.5MCG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-304b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N205382-001INCRUSE ELLIPTAEQ 62.5MCG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-3074a2ff9319b5…
2022-03-09 01:35 UTC2022-03N205382-001INCRUSE ELLIPTAEQ 62.5MCG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-30bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N205382-001INCRUSE ELLIPTAEQ 62.5MCG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-30782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N205382-001INCRUSE ELLIPTAEQ 62.5MCG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-3087673890dc5c…
2021-03-12 10:30 UTC2021-03N205382-001INCRUSE ELLIPTAEQ 62.5MCG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-305aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N205382-001INCRUSE ELLIPTAEQ 62.5MCG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-308869cabd3fbd…
2020-11-12 02:37 UTC2020-11N205382-001INCRUSE ELLIPTAEQ 62.5MCG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-30c0c555d07b60…
2019-12-14 00:12 UTC2019-12N205382-001INCRUSE ELLIPTAEQ 62.5MCG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-303f01610625f2…
2019-09-15 20:21 UTC2019-09N205382-001INCRUSE ELLIPTAEQ 62.5MCG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-30b00525d2431f…
2019-07-19 19:46 UTC2019-07N205382-001INCRUSE ELLIPTAEQ 62.5MCG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-30ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N205382-001INCRUSE ELLIPTAEQ 0.0625MG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-306a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N205382-001INCRUSE ELLIPTAEQ 0.0625MG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-301c564ffb4f44…
2023-12-20 04:57 UTC2023-12N205382-001INCRUSE ELLIPTAEQ 62.5MCG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-30ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N205382-001INCRUSE ELLIPTAEQ 62.5MCG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-30a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N205382-001INCRUSE ELLIPTAEQ 62.5MCG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-309b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N205382-001INCRUSE ELLIPTAEQ 62.5MCG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-30a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N205382-001INCRUSE ELLIPTAEQ 62.5MCG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-303f0d92c62455…
2023-05-13 08:27 UTC2023-05N205382-001INCRUSE ELLIPTAEQ 62.5MCG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-30053a50430f4f…
2023-01-26 05:58 UTC2023-01N205382-001INCRUSE ELLIPTAEQ 62.5MCG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-303bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N205382-001INCRUSE ELLIPTAEQ 62.5MCG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-303a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N205382-001INCRUSE ELLIPTAEQ 62.5MCG BASE/INHPOWDER / INHALATIONRLD, RS2014-04-30f41ea6bd6efb…

Observed Orange Book patent history#

Patent history page 1 of 9 · 346 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productPatentExpirationUse codeCoverage / statusSubmission dateSource SHA-256
2026-09-14 22:38:342026-08N205382-00174888272027-12-18Drug substance, Drug product2014-05-2184e616aacf4f…
2026-08-18 06:07:402026-07N205382-00174888272027-12-18Drug substance, Drug product2014-05-21caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N205382-00174888272027-12-18Drug substance, Drug product2014-05-21011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N205382-00174984402025-04-27Drug substance, Drug product2014-05-2131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N205382-00183095722025-04-27U-14762014-05-2131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N205382-00181832572025-07-27U-14762014-05-2131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N205382-00174888272027-12-18Drug substance, Drug product2014-05-2131067a03dcf5…
2025-08-23 18:47 UTC2025-08N205382-00174984402025-04-27Drug substance, Drug product2014-05-216a471c1ec25d…
2025-08-23 18:47 UTC2025-08N205382-00183095722025-04-27U-14762014-05-216a471c1ec25d…
2025-08-23 18:47 UTC2025-08N205382-00181832572025-07-27U-14762014-05-216a471c1ec25d…
2025-08-23 18:47 UTC2025-08N205382-00174888272027-12-18Drug substance, Drug product2014-05-216a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N205382-00174984402025-04-27Drug substance, Drug product2014-05-21fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N205382-00183095722025-04-27U-14762014-05-21fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N205382-00181832572025-07-27U-14762014-05-21fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N205382-00193333102027-10-02Drug product2016-05-20fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N205382-00174888272027-12-18Drug substance, Drug product2014-05-21fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N205382-00182015562029-02-05Drug product2014-05-21fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N205382-00187462422030-10-11Drug product2014-06-26fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N205382-00174984402025-04-27Drug substance, Drug product2014-05-21b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N205382-00183095722025-04-27U-14762014-05-21b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N205382-00181832572025-07-27U-14762014-05-21b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N205382-00193333102027-10-02Drug product2016-05-20b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N205382-00174888272027-12-18Drug substance, Drug product2014-05-21b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N205382-00182015562029-02-05Drug product2014-05-21b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N205382-00187462422030-10-11Drug product2014-06-26b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N205382-00174984402025-04-27Drug substance, Drug product2014-05-2103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N205382-00183095722025-04-27U-14762014-05-2103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N205382-00181832572025-07-27U-14762014-05-2103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N205382-00193333102027-10-02Drug product2016-05-2003ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N205382-00174888272027-12-18Drug substance, Drug product2014-05-2103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N205382-00182015562029-02-05Drug product2014-05-2103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N205382-00187462422030-10-11Drug product2014-06-2603ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N205382-00174984402025-04-27Drug substance, Drug product2014-05-212680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N205382-00183095722025-04-27U-14762014-05-212680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N205382-00181832572025-07-27U-14762014-05-212680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N205382-00193333102027-10-02Drug product2016-05-202680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N205382-00174888272027-12-18Drug substance, Drug product2014-05-212680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N205382-00182015562029-02-05Drug product2014-05-212680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N205382-00187462422030-10-11Drug product2014-06-262680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N205382-00174984402025-04-27Drug substance, Drug product2014-05-215bbf6a4d5a75…

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
CapturedEditionApplication-productExclusivity codeExpirationSource SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N205382-001M-2452022-06-095c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N205382-001M-2452022-06-095d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N205382-001M-2452022-06-094b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N205382-001M-1722019-02-2474a2ff9319b5…
2022-03-09 01:35 UTC2022-03N205382-001M-2452022-06-09bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N205382-001M-2452022-06-09782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N205382-001M-2452022-06-0987673890dc5c…
2021-03-12 10:30 UTC2021-03N205382-001M-2452022-06-095aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N205382-001M-2452022-06-098869cabd3fbd…
2020-11-12 02:37 UTC2020-11N205382-001M-2452022-06-09c0c555d07b60…
2019-12-14 00:12 UTC2019-12N205382-001M-1722019-02-243f01610625f2…
2019-09-15 20:21 UTC2019-09N205382-001M-1722019-02-24b00525d2431f…
2019-07-19 19:46 UTC2019-07N205382-001M-1722019-02-24ea99ee380514…
2023-01-26 05:58 UTC2023-01N205382-001M-2452022-06-093bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N205382-001M-2452022-06-093a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N205382-001M-2452022-06-09f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N205382-001M-2452022-06-09e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N205382-001M-2452022-06-09cb3db0bc1861…

Additional Listing Data#

Finished product
Yes
Brand name base
Incruse Ellipta
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
UMECLIDINIUM BROMIDE62.5 ug/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
7AN603V4JVInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1539251Internal RxNorm lookup
1539885Internal RxNorm lookup
1596444Internal RxNorm lookup
1596445Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
dbb64747-1505-49d7-9a33-99dd402e96d3Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
b8f051f0-c83d-4101-9511-7c3765599726Product name120190910
c982201d-72cb-462f-9e02-902ec0d4a295Product name120181030
9f9452df-fa34-43d4-97fe-c6605344c5a8Product name120171113

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0173-0873-06Incruse Ellipta1 in 1 CARTONAEROSOL, POWDER127
0173-0873-06Incruse Ellipta1 in 1 TRAYAEROSOL, POWDER127
0173-0873-10Incruse Ellipta1 in 1 TRAYAEROSOL, POWDER127
0173-0873-10Incruse Ellipta1 in 1 CARTONAEROSOL, POWDER127

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0173-0873-06EA - Each0173-0873bb966823-bab6-4cec-872b-db9eb7f63b0a12015-01-05
0173-0873-10EA - Each0173-087334214c66-8b12-45c1-a06b-3869a8a90a9812015-01-05

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
UMECLIDINIUM BROMIDEACTIVE INGREDIENT7AN603V4JVINCRUSE ELLIPTA (UMECLIDINIUM) AEROSOL, POWDER [GLAXOSMITHKLINE LLC]5
UMECLIDINIUMACTIVE MOIETYGE2T1418SVINCRUSE ELLIPTA (UMECLIDINIUM) AEROSOL, POWDER [GLAXOSMITHKLINE LLC]5
LACTOSE MONOHYDRATEINACTIVE INGREDIENTEWQ57Q8I5XINCRUSE ELLIPTA (UMECLIDINIUM) AEROSOL, POWDER [GLAXOSMITHKLINE LLC]5
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30INCRUSE ELLIPTA (UMECLIDINIUM) AEROSOL, POWDER [GLAXOSMITHKLINE LLC]5

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0173-0873INCRUSE ELLIPTA (UMECLIDINIUM) AEROSOL, POWDER [GLAXOSMITHKLINE LLC]25Current NDC, Legacy NDC, 4 package rows20250525_dbb64747-1505-49d7-9a33-99dd402e96d3.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Umeclidinium ElliptaUMECLIDINIUMPrasco Laboratories763388a5-cc89-4c25-8562-521df679b7e82025-11-06Warnings, Adverse reactionsExact identifier
application applno (NDA): 205382
application number: NDA205382
Incruse ElliptaUMECLIDINIUMGlaxoSmithKline LLCdbb64747-1505-49d7-9a33-99dd402e96d32023-12-13Warnings, Adverse reactionsExact identifier
application applno (NDA): 205382
application number: NDA205382
ndc (product): 0173-0873

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1539885Incruse Ellipta 62.5 MCG/INHAL Dry Powder Inhaler, 30 BlistersPSNdbb64747-1505-49d7-9a33-99dd402e96d327
1596445Incruse Ellipta 62.5 MCG/INHAL Dry Powder Inhaler, 7 BlistersPSNdbb64747-1505-49d7-9a33-99dd402e96d327
1539251umeclidinium 62.5 MCG/INHAL Dry Powder Inhaler, 30 BlistersPSNdbb64747-1505-49d7-9a33-99dd402e96d327
1596444umeclidinium 62.5 MCG/INHAL Dry Powder Inhaler, 7 BlistersPSNdbb64747-1505-49d7-9a33-99dd402e96d327
153988530 ACTUAT umeclidinium 0.0625 MG/ACTUAT Dry Powder Inhaler [Incruse]SBDdbb64747-1505-49d7-9a33-99dd402e96d327
15964457 ACTUAT umeclidinium 0.0625 MG/ACTUAT Dry Powder Inhaler [Incruse]SBDdbb64747-1505-49d7-9a33-99dd402e96d327
153925130 ACTUAT umeclidinium 0.0625 MG/ACTUAT Dry Powder InhalerSCDdbb64747-1505-49d7-9a33-99dd402e96d327
15964447 ACTUAT umeclidinium 0.0625 MG/ACTUAT Dry Powder InhalerSCDdbb64747-1505-49d7-9a33-99dd402e96d327
1539885Incruse Ellipta (umeclidinium 62.5 MCG) per ACTUAT Dry Powder Inhaler, 30 ACTUATSYdbb64747-1505-49d7-9a33-99dd402e96d327
1596445Incruse Ellipta (umeclidinium 62.5 MCG) per ACTUAT Dry Powder Inhaler, 7 ACTUATSYdbb64747-1505-49d7-9a33-99dd402e96d327
1539885Incruse Ellipta 62.5 MCG/INHAL Dry Powder Inhaler, 30 BlistersSYdbb64747-1505-49d7-9a33-99dd402e96d327
1596445Incruse Ellipta 62.5 MCG/INHAL Dry Powder Inhaler, 7 BlistersSYdbb64747-1505-49d7-9a33-99dd402e96d327
1539251umeclidinium 62.5 MCG/INHAL Dry Powder Inhaler, 30 BlistersSYdbb64747-1505-49d7-9a33-99dd402e96d327
1596444umeclidinium 62.5 MCG/INHAL Dry Powder Inhaler, 7 BlistersSYdbb64747-1505-49d7-9a33-99dd402e96d327

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
0173-0873-06001730873061 TRAY in 1 CARTON (0173-0873-06) / 1 INHALER in 1 TRAY / 7 AEROSOL, POWDER in 1 INHALER1 tray2014-04-300000-00-00NoNoCurrent
0173-0873-10001730873101 TRAY in 1 CARTON (0173-0873-10) / 1 INHALER in 1 TRAY / 30 AEROSOL, POWDER in 1 INHALER1 tray2014-04-300000-00-00NoNoCurrent
0173-0873-61001730873611 TRAY in 1 CARTON (0173-0873-61) > 1 INHALER in 1 TRAY > 7 AEROSOL, POWDER in 1 INHALER1 tray2014-04-300000-00-00NoNoCurrent